Suppr超能文献

普伐他汀缓释制剂的统计设计与优化

Statistical Design and Optimization of Sustained Release Formulations of Pravastatin.

作者信息

Gunda Raghavendra Kumar, Manchineni Prasada Rao

机构信息

MAM College of Pharmacy, Department of Pharmaceutics, Andhra Pradesh, India.

MAM College of Pharmacy, Department of Pharmaceutical Analysis, Andhra Pradesh, India.

出版信息

Turk J Pharm Sci. 2020 Apr;17(2):221-227. doi: 10.4274/tjps.galenos.2019.70048. Epub 2020 Apr 24.

Abstract

OBJECTIVES

The objective of the current study was to formulate a sustained release (SR) formulation for pravastatin. Pravastatin is a lipid lowering, biopharmaceutical classification class-III agent.

MATERIALS AND METHODS

SR tablets of pravastatin were prepared using variable amounts of hydroxy methyl propyl cellulose (HPMC) K4M and sodium carboxy methyl cellulose in various proportions by direct compression in a 3 factorial design. The amounts of the polymers HPMC K4M and sodium carboxy methyl cellulose required to obtain prolonged release of drug were chosen as independent variables, X and X, respectively, whereas times taken for 10%, 50%, 75%, and 90% drug release were chosen as dependent variables.

RESULTS

Nine formulations were developed and were checked using pharmacopoeial tests. The results showed that all the factorial batches were within the standard limits. The dissolution parameters of all formulations were subjected to kinetic fitting and various statistical parameters were determined. Polynomial equations were developed and verified for dependent variables. Formulation F, containing 25 mg of HPMC K4M and 25 mg of sodium carboxy methyl cellulose, was the formulation most similar (similarity factor f=89.559, difference factor f=1.546) to the marketed product (Pravachol).

CONCLUSION

The best formulation (F) follows Higuchi's kinetics and non-Fickian diffusion zero order kinetics (n=1.083).

摘要

目的

本研究的目的是制备普伐他汀的缓释(SR)制剂。普伐他汀是一种降脂的生物药剂学分类III类药物。

材料与方法

采用不同比例的羟丙基甲基纤维素(HPMC)K4M和羧甲基纤维素钠,通过直接压片法,以三因素设计制备普伐他汀缓释片。将获得药物缓释所需的聚合物HPMC K4M和羧甲基纤维素钠的用量分别选为自变量X和X,而将药物释放10%、50%、75%和90%所需的时间选为因变量。

结果

开发了9种制剂,并采用药典试验进行检查。结果表明,所有析因批次均在标准限度内。对所有制剂的溶出参数进行动力学拟合,并确定各种统计参数。建立并验证了因变量的多项式方程。含有25mg HPMC K4M和25mg羧甲基纤维素钠的制剂F与市售产品(普拉固)最相似(相似因子f=89.559,差异因子f=1.546)。

结论

最佳制剂(F)符合Higuchi动力学和非Fickian扩散零级动力学(n=1.083)。

相似文献

1
Statistical Design and Optimization of Sustained Release Formulations of Pravastatin.普伐他汀缓释制剂的统计设计与优化
Turk J Pharm Sci. 2020 Apr;17(2):221-227. doi: 10.4274/tjps.galenos.2019.70048. Epub 2020 Apr 24.
4
Development of Bioadhesive Buccal Tablets of Nicorandil Using a Factorial Approach.采用析因法开发尼可地尔生物黏附性口腔片。
Turk J Pharm Sci. 2020 Aug;17(4):388-397. doi: 10.4274/tjps.galenos.2019.09226. Epub 2020 Aug 28.

本文引用的文献

5
Buccal drug delivery of pravastatin sodium.口腔给达泊西汀钠。
AAPS PharmSciTech. 2010 Mar;11(1):416-24. doi: 10.1208/s12249-010-9381-4. Epub 2010 Mar 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验